Horvath E - Search Results

1

Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy.

Devemy E, Li B, Tao M, Horvath E, Chopra H, Fisher L, Nayini J, Creech S, Venugopal P, Yang J, Kaspar C, Hsu W, Preisler HD. Devemy E, et al. Among authors: horvath e. Leuk Res. 2001 Sep;25(9):783-91. doi: 10.1016/s0145-2126(01)00032-7. Leuk Res. 2001. PMID: 11489472

2

Cytokine gene activity in AML cells in vivo in patients.

Gao XZ, Bi S, Copra H, Devemy E, Venugopal P, Li B, Hsu WT, Loew J, Galvez A, Gregory S, Yang J, Horvath E, Preisler HD. Gao XZ, et al. Among authors: horvath e. Leuk Res. 1998 May;22(5):429-38. doi: 10.1016/s0145-2126(98)00024-1. Leuk Res. 1998. PMID: 9652729 Clinical Trial.

3

Telomerase activity in preleukemia and acute myelogenous leukemia.

Li B, Yang J, Andrews C, Chen YX, Toofanfard P, Huang RW, Horvath E, Chopra H, Raza A, Preisler HD. Li B, et al. Among authors: horvath e. Leuk Lymphoma. 2000 Feb;36(5-6):579-87. doi: 10.3109/10428190009148406. Leuk Lymphoma. 2000. PMID: 10784403

4

Poor prognosis acute myelogenous leukemia 2--biological and molecular biological characteristics and treatment outcome.

Li B, Yang J, Tao M, Nayini J, Horvath E, Chopra H, Meyer P, Venugopal P, Preisler HD. Li B, et al. Among authors: horvath e. Leuk Res. 2000 Sep;24(9):777-89. doi: 10.1016/s0145-2126(00)00035-7. Leuk Res. 2000. PMID: 10978783

5

Assessment of apoptosis in relation to proliferation and mutational status of p53 gene in head and neck cancers.

Mundle S, Kotelnikov V, Wood N, Coon J, Horvath E, Taylor S, Lafollette S, Caldarelli D, Hutchinson J, Panje W, Preisler H, Raza A. Mundle S, et al. Among authors: horvath e. Int J Oncol. 1996 Jun;8(6):1257-64. doi: 10.3892/ijo.8.6.1257. Int J Oncol. 1996. PMID: 21544492

6

Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.

Wang H, Lindsey S, Konieczna I, Bei L, Horvath E, Huang W, Saberwal G, Eklund EA. Wang H, et al. Among authors: horvath e. J Biol Chem. 2009 Jan 23;284(4):2549-67. doi: 10.1074/jbc.M804704200. Epub 2008 Nov 19. J Biol Chem. 2009. PMID: 19022774 Free PMC article.

7

HoxA10 influences protein ubiquitination by activating transcription of ARIH2, the gene encoding Triad1.

Wang H, Bei L, Shah CA, Horvath E, Eklund EA. Wang H, et al. Among authors: horvath e. J Biol Chem. 2011 May 13;286(19):16832-45. doi: 10.1074/jbc.M110.213975. Epub 2011 Mar 28. J Biol Chem. 2011. PMID: 21454682 Free PMC article.

8

Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia.

Konieczna I, Horvath E, Wang H, Lindsey S, Saberwal G, Bei L, Huang W, Platanias L, Eklund EA. Konieczna I, et al. Among authors: horvath e. J Clin Invest. 2008 Mar;118(3):853-67. doi: 10.1172/JCI33742. J Clin Invest. 2008. PMID: 18246201 Free PMC article.

9

HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells.

Bei L, Huang W, Wang H, Shah C, Horvath E, Eklund E. Bei L, et al. Among authors: horvath e. J Biol Chem. 2011 May 27;286(21):19047-64. doi: 10.1074/jbc.M110.213983. Epub 2011 Apr 6. J Biol Chem. 2011. PMID: 21471217 Free PMC article.

10

Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein.

Huang W, Saberwal G, Horvath E, Zhu C, Lindsey S, Eklund EA. Huang W, et al. Among authors: horvath e. Mol Cell Biol. 2006 Sep;26(17):6311-32. doi: 10.1128/MCB.00036-06. Mol Cell Biol. 2006. PMID: 16914719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,073 results

Search Page